Thanks for your post Mozz. Not sure if my understanding is right here. Do you mean if we get statistically significant improved (p<0.05) for Pain at WOMAC scores at day53 in PARA_008, no serious AEs, even though secondary endpoints not met, we will still get FDA approved?
Thanks for your post Mozz. Not sure if my understanding is right...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $130.6K | 643.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 65788 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 10008 | 2 |
View Market Depth
| Last trade - 13.11pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |